Biofrontera
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $17,100 | $6,988 | $9,030 | $8,588 |
Gross Profit | 14,366 | 5,066 | 6,650 | 5,513 |
EBITDA | 4,778 | -6,333 | -4,966 | -3,865 |
EBIT | 4,558 | -6,532 | -5,188 | -4,084 |
Net Income | 5,640 | -6,649 | -5,324 | -4,203 |
Net Change In Cash | 17,100 | 6,988 | 9,030 | 8,588 |
Free Cash Flow | -2,375 | -3,822 | -3,046 | -4,120 |
Cash | 6,392 | 3,417 | 7,239 | 1,785 |
Basic Shares | 11,648 | 10,776 | 9,351 | 5,516 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $41,705 | $37,303 | $34,071 | $28,674 |
Gross Profit | 31,594 | 18,696 | 16,627 | 13,489 |
EBITDA | -10,480 | -14,441 | -18,453 | 934 |
EBIT | -11,348 | -15,590 | -19,517 | -238 |
Net Income | -10,536 | -17,759 | -20,131 | -640 |
Net Change In Cash | 41,705 | 37,303 | 34,071 | 28,674 |
Free Cash Flow | -13,363 | -10,330 | -24,900 | -16,237 |
Cash | 6,392 | 5,905 | 1,343 | 17,208 |
Basic Shares | 11,648 | 5,516 | 1,546 | 1,056 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0.49 |
2025-09-30 | -$0.62 |
2025-06-30 | -$0.57 |
2025-03-31 | -$0.50 |
